Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer

Ann Transl Med. 2022 Nov;10(21):1184. doi: 10.21037/atm-22-4581.

Authors

Jan Stenvang¹, Peter Michael Vestlev², Benny Vittrup Jensen³, Per Pfeiffer⁴

Affiliations

¹ Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
² Department of Oncology, Zealand University Hospital, Roskilde - Naestved, Denmark.
³ Department of Oncology, Herlev and Gentofte Hospital, Herlev, Denmark.
⁴ Department of Oncology, Odense University Hospital, Odense, Denmark.

No abstract available

Publication types

Editorial
Comment